As unusual as it may seem for some people, sometimes indicators of diseases may lie in what we flush out of our bodies, like our stools. The color may be an indicator of something as serious as stomach cancer.
One of the types of cancer that plague a portion of the world’s population is stomach cancer. While it is not as prevalent as the other types such as lung cancer, it is still serious and must be treated before it gets worse. Express reports that an indicator that a person may have the disease is in the color of the stool. The color of the stool usually indicates how healthy a person is, and in this case, if the stool is very dark, almost black in color, then it may be a symptom of stomach cancer.
Then again, the color of the stool may also be affected by the medication being taken as well as the kind of food or drinks being eaten. According to Cancer Research UK, a person’s stool may also be the same dark, almost-black color if they take iron tablets.
At the same time, blood in the stool may also indicate the disease. However, as with any illness, these symptoms may be indicators for other diseases so it is still best to check with a physician, who can give a proper test. The symptoms of stomach cancer may also overlap with symptoms of stomach ulcers or other conditions that may not be as serious.
Meanwhile, there are kinds of food that do affect the color of the stools. Seeing a different color may seem alarming but before the panic sets in, it is also good to think about what kind of food you may have eaten. Beets may affect the color of the stool and turn it into a dark red color, almost like blood.
In case the stool in the toilet is of a greenish hue, then veggies are the likely cause. Green stools are usually harmless and do not really indicate serious issues, such as diarrhea, salmonella infections, and stomach cramps. Blueberries may also be the cause of a blueish tinge in the stool.


Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Vanda Pharmaceuticals (VNDA) Stock Soars After FDA Approves BYSANTI for Bipolar I and Schizophrenia
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Why the future of marijuana legalization remains hazy despite high public support
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand 



